Adjuvant chemotherapy for gastric cancer

Gastric cancer remains one of the most interesting problem of the oncology. Combined approach is recommended for treatment of gastric cancer patients and it use almost in all countries of the world. The role of adjuvant chemotherapy for patients with gastric cancer discusses since the mid of XX cent...

Full description

Saved in:
Bibliographic Details
Main Authors: I. P. Kolesnyk, A. I. Shevchenko
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2015-12-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/56306/54643
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gastric cancer remains one of the most interesting problem of the oncology. Combined approach is recommended for treatment of gastric cancer patients and it use almost in all countries of the world. The role of adjuvant chemotherapy for patients with gastric cancer discusses since the mid of XX century. Aim. This critical review consider the basic clinical research on this issue. It was found that the results of studies from theUSand European countries differ significantly from the results obtained in the works from Japan and Korea. According to clinical studies, adjuvant chemotherapy has demonstrated its efficacy only in patients 'eastern' population with a D2 lymph node dissection. At the same time, this chemotherapy regimen was not effective in patients of 'Western' populations. In this case, most of the works from the US and Europe had limited volume of lymph node dissection. Conclusion. It is very important to start new investigations for studying the role of adjuvant chemotherapy for patients from «west» region after radical operation with D2 lymph node dissection.
ISSN:2306-4145
2310-1210